Viridian Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Updates

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. QCOM
2. FDX
3. CBRS
4. USO
5. SPY
6. MU
7. KBH
8. HON
9. HTZ
10. JPM

Go back to Viridian Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Updates

Viridian Therapeutics, Inc. (VRDN) Reports Q4 Loss of $1.13/sh

March 8, 2023 7:09 AM EST

Viridian Therapeutics, Inc. (NASDAQ: VRDN) reported Q4 EPS of ($1.13), versus $1.31 reported last year. Revenue for the quarter came in at $105 thousand, versus $214 thousand reported last year.

For earnings history and earnings-related data on Viridian Therapeutics, Inc. (VRDN) click here.

... More